Concerns over AstraZeneca vaccine disrupts vaccination campaigns
On
DR Congo postpones roll-out
By Sola Ogundipe & Chioma Obinna
The spate of concerns over COVID-19 vaccines and the AstraZeneca-Oxford vaccine, in particular, is fast constituting a threat to vaccination campaign plans globally.
Not less than 20 countries in Europe, Asia, and Africa, have either suspended or postponed their COVID-19 vaccination campaign plans.
The key concerns are the cases of bleeding, blood clots, and low platelet counts among people who received the AstraZeneca shot.
As the World Health Organisation (WHO) reviews the available vaccine data and addresses the concerns, global health experts are under increasing pressure to clear up questions over the safety of the AstraZeneca shot, just as more countries in Europe fully or partially suspended their use of the vaccine in a further blow to Europe’s vaccination rollout.